North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on July 2, 2026

41 minutes ago

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

Indeterminate GlobeNewswire

43 minutes ago

Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

Indeterminate GlobeNewswire

an hour ago

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders

Indeterminate GlobeNewswire

an hour ago

Burning Rock Announces Founder’s Purchase of Its ADSs

Indeterminate GlobeNewswire

an hour ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

an hour ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

Indeterminate GlobeNewswire

an hour ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Vireo Growth Inc. Announces Pennsylvania Dispensary License Transaction, Expanding into its 11th State

Indeterminate GlobeNewswire

an hour ago

Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Indeterminate GlobeNewswire

2 hours ago

Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer

Indeterminate GlobeNewswire

2 hours ago

The Ensign Group Purchases Real Estate and Operations in Texas

Indeterminate GlobeNewswire

4 hours ago

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

Indeterminate GlobeNewswire

4 hours ago

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

Indeterminate GlobeNewswire

4 hours ago

Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer

Indeterminate GlobeNewswire

5 hours ago

Xeltis exceeds 50% enrollment in US Pivotal trial for aXess™, its vascular access device for hemodialysis

Indeterminate GlobeNewswire

6 hours ago

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Indeterminate GlobeNewswire

6 hours ago

Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)

Indeterminate GlobeNewswire

7 hours ago

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Indeterminate GlobeNewswire

8 hours ago

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire